Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

BACKGROUND: Patients aged 65 years and older represent the majority of patients with metastatic colorectal cancer (mCRC). However, this patient population is often underrepresented in clinical trials and probably undertreated in the clinical practice. METHODS: We have analysed the outcomes of 3,187...

Descripción completa

Detalles Bibliográficos
Autores principales: Slavicek, Lubomir, Pavlik, Tomas, Tomasek, Jiri, Bortlicek, Zbynek, Buchler, Tomas, Melichar, Bohuslav, Vyzula, Rostislav, Prausova, Jana, Finek, Jindrich, Majek, Ondrej, Dusek, Ladislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987650/
https://www.ncbi.nlm.nih.gov/pubmed/24666582
http://dx.doi.org/10.1186/1471-230X-14-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987650/
https://www.ncbi.nlm.nih.gov/pubmed/24666582
http://dx.doi.org/10.1186/1471-230X-14-53

Ejemplares similares